Ulcerative colitis in remission (n = 55) | Controls (n = 33) | p-value | |
---|---|---|---|
Mean age years (SD) | 49 (14.2) | 52 (10.2) | 0.27 |
Women | 45% | 60% | 0.03* |
Median disease duration in years (IQR) | 17.5 (17) | ||
Montreal classification: | |||
A1 | 18% | ||
A2 | 67% | ||
A3 | 15% | ||
E1 | 0% | ||
E2 | 20% | ||
E3 | 80% | ||
5-ASA | 85% | ||
Immune modulators | 20% | ||
Biologics | 2% | ||
Median fecal calprotectin μg/g (IQR) | 37 (42) | 21 (18) | <0.02* |